Fenofibrate and Adalat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fenofibrate (fenofibrate) and Adalat (nifedipine). Common drug interactions include white blood cell count increased among females and general physical health deterioration among males.

The phase IV clinical study analyzes what interactions people have when they take Fenofibrate and Adalat. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

On Aug, 01, 2026

46 people who take Fenofibrate and Adalat together, and have interactions are studied.

Fenofibrate and Adalat drug interactions.

What are the common drug interactions of Fenofibrate and Adalat, by gender? *:

female:

White blood cell count increased
Pneumonia
Renal failure (kidney dysfunction)
Chronic kidney disease
Death
Influenza
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Depressed level of consciousness
Extrasystoles

male:

General physical health deterioration (weak health status)
Acute respiratory distress syndrome
Pulmonary cavitation (cavity in the lung)
Red blood cell sedimentation rate increased
Renal impairment (severely reduced kidney function)
Septic shock (shock due to blood infection)
Synovitis (inflammation of the synovial membrane)
Urinary tract infection
Vomiting
Death

What are the common drug interactions of Fenofibrate and Adalat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Pulmonary cavitation (cavity in the lung)
Renal cell carcinoma (a kidney cancer)

50-59:

Influenza
Pneumonia
Hypersensitivity
Abdominal pain upper
Back pain
Blood amylase increased
Blood pressure systolic increased
Dysgeusia (disorder of the sense of taste)
Fat tissue increased
Gait disturbance

60+:

Death
Pneumonia
Red blood cell sedimentation rate increased
Renal impairment (severely reduced kidney function)
Septic shock (shock due to blood infection)
Synovitis (inflammation of the synovial membrane)
Urinary tract infection
Vomiting
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the existing conditions these people have? *

Diabetes: 7 people, 15.22%
Pain: 7 people, 15.22%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 8.70%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 8.70%
Dyspnea (difficult or laboured breathing): 4 people, 8.70%
Multiple Myeloma (cancer of the plasma cells): 4 people, 8.70%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 6.52%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 6.52%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.52%
General Anaesthesia: 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and Adalat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously